XVIVO

medical animation of CRISPR gene editing is groundbreaking but complex. For Intellia Therapeutics, we created a patient-friendly animated experience to help clinical trial participants understand how CRISPR works- clearly, accurately, and with a sense of warmth and curiosity.
medical animation of We partnered with Reselute to build a 3D Medical device animation around their Reselution™ Intramedullary Fixation System, focusing on what makes it different and why it matters in the context of high-risk fractures. The piece takes the audience from the clinical problem into the surgical workflow, showing how the device is prepared and used in the operating room.
medical animation of We partnered with Cleveland Diagnostics to develop a 1:20-minute medical animation introducing IsoPSA, a next-generation blood test designed to improve prostate cancer risk assessment. Our challenge was to show how IsoPSA moves beyond traditional PSA testing in a way physicians and patients could immediately understand.
medical animation of For the launch of their booth at ISCT 2025 in New Orleans, and the debut of their new website, VitaCyte partnered with XVIVO to create a two-minute medical animation that details the science of cell recovery. Working with the VitaCyte team is always a highlight for us, and this project was a perfect mix of collaboration and science communication.
medical animation of Celldex returned to XVIVO to create a medical animation explaining the mechanism behind barzolvolimab, a monoclonal antibody that targets mast cells. After first working together in 2011, collaborating again with Celldex founder and CSO, Dr. Tibor Keler, made this project both meaningful and a reminder of why we love telling science stories.
medical animation of Biohaven Pharmaceuticals and XVIVO teamed up again, this time to create a mechanism of action animation for BHV-7000, their recently-acquired Kv7 activator. The BHV-7000 molecule blocks the action of the voltage-gated Kv7 potassium ion channel, which exquisitely regulates the excitability of neurons in the central nervous system.
medical animation of Sickle cell disease is an inherited genetic disease that has serious impacts on the people living with it. Forma Therapeutics is fiercely dedicated to improving the lives of these patients. XVIVO and Forma partnered together for multiple medical animation projects to educate both healthcare professionals and patients on their scientific approach.
medical animation of Moderna was creating a curriculum to inspire and educate learners about the opportunity mRNA presents as a medicine. The objective was to create an engaging online lecture that would serve both internal company training and public education. For XVIVO, it involved producing over 30 minutes of high-quality 3D animation focusing on mRNA technology, molecular and cellular processes, and therapeutic advancements.
medical animation of XVIVO and Korro Bio continued their partnership to create an animation for Korro’s RNA editing oligonucleotide candidate for alpha-1 antitrypsin deficiency (AATD) from their proprietary OPERA™ platform. The purpose of the animation was to illustrate the unmet need for AATD patients, the role of the protein AAT in the disease, and the promise of Korro’s RNA editing candidate.
medical animation of We collaborated with Max Hodak, the CEO of Science Corporation, to create a 3D animation to accurately and beautifully depict their breakthrough biohybrid technology. The animation showcases the architecture of their system and illustrates how their innovative technology facilitates communication to and from the brain.

Profile

XVIVO Scientific Animation is an award-winning medical animation studio with over 25 years of experience translating complex science into clear, compelling, and memorable visuals. Based in Wethersfield, Connecticut, XVIVO serves a wide range of clients across the life sciences, from global pharmaceutical leaders like Johnson & Johnson, Pfizer, Moderna, and Ipsen, to pioneering biotech companies, medical device innovators, and early-stage startups. Academic and government partners have included Harvard University, St. Jude Children's Research Hospital, the Children's Hospital of Philadelphia (CHOP), and the National Institutes of Health. XVIVO's team of Certified Medical Illustrators, PhD script writers, and seasoned 3D artists brings deep scientific expertise and visual thinking to every project. Their services span 3D and 2D animation, medical illustration, interactive touch screen experiences, as well as virtual and augmented reality. The studio is perhaps best known for creating The Inner Life of the Cell, a landmark animation developed in partnership with Harvard University that became a defining moment in the field of scientific visualization. XVIVO's work has been featured in The New York Times, shown at TED and TEDMED, exhibited at the Museum of Modern Art, and presented at the World Science Festival and the World Economic Forum, bringing cutting-edge science to various audiences across the globe. With an average staff tenure of over ten years and hundreds of successful programs completed, XVIVO brings a rare combination of scientific credibility, creative excellence, and a truly collaborative spirit to every project. Underlying all of it is a deeply held belief that science needs to be understood, not just by specialists, but by patients, caregivers, investors, and the broader public. Because when people understand their own biology, how diseases can unfold, and what science makes possible, lives improve.

Style/Techniques

Animation, Cartoon, 3D, Video, Voiceovers/Narration

Subject/Specialties

Biotechnology, Cell biology / Histology, Disease Management, General Surgery, Genetics, Medical Devices, Molecular Biology, Neuroscience, Neurosurgery, Virology, Injuries, Oncology, Mechanism of Action (MOA), Hemophilia